Literature DB >> 30045868

Lower Airway Bacterial Colonization Patterns and Species-Specific Interactions in Chronic Obstructive Pulmonary Disease.

David M Jacobs1, Heather M Ochs-Balcom2, Jiwei Zhao3, Timothy F Murphy4, Sanjay Sethi4.   

Abstract

Little is known about interactions between nontypeable Haemophilus influenzae, Moraxella catarrhalis, Streptococcus pneumoniae, and Pseudomonas aeruginosa in the lower respiratory tract in chronic obstructive pulmonary disease (COPD) patients. We characterized colonization by these four bacterial species, determined species-specific interactions, and estimated the effects of host factors on bacterial colonization among COPD patients. We conducted a prospective cohort study in veterans with COPD that involved monthly clinical assessment and sputum cultures with an average duration of follow-up of 4.5 years. Cultures were used for bacterial identification. We analyzed bacterial interactions using generalized linear mixed models after controlling for clinical and demographic variables. The outcomes of interest were the relationships between bacteria based on clinical status (stable or exacerbation). One hundred eighty-one participants completed a total of 8,843 clinic visits, 30.8% of which had at least one of the four bacteria isolated. H. influenzae was the most common bacterium isolated (14.4%), followed by P. aeruginosa (8.1%). In adjusted models, S. pneumoniae colonization was positively associated with H. influenzae colonization (odds ratio [OR], 2.79; 95% confidence interval [CI], 2.03 to 3.73). We identified negative associations between P. aeruginosa and H. influenzae (OR, 0.15; 95% CI, 0.10 to 0.22) and P. aeruginosa and M. catarrhalis (OR, 0.51; 95% CI, 0.35 to 0.75). Associations were similar during stable and exacerbation visits. Recent antimicrobial therapy was associated with a lower prevalence of S. pneumoniae, H. influenzae, and M. catarrhalis, but not P. aeruginosa Our findings support the presence of specific interspecies interactions between common bacteria in the lower respiratory tracts of COPD patients. Further work is necessary to elucidate the mechanisms of these complex interactions that shift bacterial species.
Copyright © 2018 American Society for Microbiology.

Entities:  

Keywords:  COPD; bacterial colonization; exacerbations; interactions

Mesh:

Year:  2018        PMID: 30045868      PMCID: PMC6156310          DOI: 10.1128/JCM.00330-18

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  44 in total

Review 1.  Infection in the pathogenesis and course of chronic obstructive pulmonary disease.

Authors:  Sanjay Sethi; Timothy F Murphy
Journal:  N Engl J Med       Date:  2008-11-27       Impact factor: 91.245

2.  Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function.

Authors:  J Eller; A Ede; T Schaberg; M S Niederman; H Mauch; H Lode
Journal:  Chest       Date:  1998-06       Impact factor: 9.410

Review 3.  Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective.

Authors:  Anders Folkesson; Lars Jelsbak; Lei Yang; Helle Krogh Johansen; Oana Ciofu; Niels Høiby; Søren Molin
Journal:  Nat Rev Microbiol       Date:  2012-11-13       Impact factor: 60.633

4.  Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD.

Authors:  M Miravitlles; C Espinosa; E Fernández-Laso; J A Martos; J A Maldonado; M Gallego
Journal:  Chest       Date:  1999-07       Impact factor: 9.410

5.  Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease.

Authors:  J J Soler-Cataluña; M A Martínez-García; P Román Sánchez; E Salcedo; M Navarro; R Ochando
Journal:  Thorax       Date:  2005-07-29       Impact factor: 9.139

6.  Viral-bacterial interactions and risk of acute otitis media complicating upper respiratory tract infection.

Authors:  Melinda M Pettigrew; Janneane F Gent; Richard B Pyles; Aaron L Miller; Johanna Nokso-Koivisto; Tasnee Chonmaitree
Journal:  J Clin Microbiol       Date:  2011-09-07       Impact factor: 5.948

7.  Pseudomonas aeruginosa in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Karen Eschberger; Phyllis Lobbins; Lori Grove; Xueya Cai; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2008-01-17       Impact factor: 21.405

8.  Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations.

Authors:  I S Patel; T A R Seemungal; M Wilks; S J Lloyd-Owen; G C Donaldson; J A Wedzicha
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

9.  Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Timothy F Murphy; Aimee L Brauer; Andrew T Schiffmacher; Sanjay Sethi
Journal:  Am J Respir Crit Care Med       Date:  2004-04-29       Impact factor: 21.405

10.  Nasopharyngeal bacterial interactions in children.

Authors:  Qingfu Xu; Anthony Almudervar; Janet R Casey; Michael E Pichichero
Journal:  Emerg Infect Dis       Date:  2012-11       Impact factor: 6.883

View more
  7 in total

1.  Nontypeable Haemophilus influenzae Type IV Pilus Mediates Augmented Adherence to Rhinovirus-Infected Human Airway Epithelial Cells.

Authors:  Stephen L Toone; Michelle Ratkiewicz; Laura A Novotny; Binh L Phong; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2020-08-19       Impact factor: 3.441

2.  Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort.

Authors:  Kristopher Opron; Lesa A Begley; John R Erb-Downward; Christine Freeman; Siddharth Madapoosi; Neil E Alexis; Igor Barjaktarevic; R Graham Barr; Eugene R Bleecker; Russell P Bowler; Stephanie A Christenson; Alejandro P Comellas; Christopher B Cooper; David J Couper; Claire M Doerschuk; Mark T Dransfield; MeiLan K Han; Nadia N Hansel; Annette T Hastie; Eric A Hoffman; Robert J Kaner; Jerry Krishnan; Wanda K O'Neal; Victor E Ortega; Robert Paine; Stephen P Peters; J Michael Wells; Prescott G Woodruff; Fernando J Martinez; Jeffrey L Curtis; Gary B Huffnagle; Yvonne J Huang
Journal:  NPJ Biofilms Microbiomes       Date:  2021-02-05       Impact factor: 8.462

3.  Sulforaphane suppresses lipopolysaccharide- and Pam3CysSerLys4-mediated inflammation in chronic obstructive pulmonary disease via toll-like receptors.

Authors:  Xiaoli Zeng; Xiaoju Liu; Hairong Bao
Journal:  FEBS Open Bio       Date:  2021-05-01       Impact factor: 2.693

4.  Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield.

Authors:  D Markussen; M Ebbesen; S Serigstad; H M S Grewal; Ø Kommedal; L Heggelund; C H van Werkhoven; D Faurholt-Jepsen; T W Clark; C Ritz; E Ulvestad; R Bjørneklett; S T Knoop
Journal:  Sci Rep       Date:  2022-01-10       Impact factor: 4.379

5.  Peripheral blood microbial signatures in current and former smokers.

Authors:  Jarrett D Morrow; Peter J Castaldi; Robert P Chase; Jeong H Yun; Sool Lee; Yang-Yu Liu; Craig P Hersh
Journal:  Sci Rep       Date:  2021-10-06       Impact factor: 4.996

6.  Phase Variation in HMW1A Controls a Phenotypic Switch in Haemophilus influenzae Associated with Pathoadaptation during Persistent Infection.

Authors:  Ariadna Fernández-Calvet; Begoña Euba; Celia Gil-Campillo; Arancha Catalan-Moreno; Javier Moleres; Sara Martí; Alexandra Merlos; Jeroen D Langereis; Francisco García-Del Portillo; Lauren O Bakaletz; Garth D Ehrlich; Eric A Porsch; Margarita Menéndez; Joshua C Mell; Alejandro Toledo-Arana; Junkal Garmendia
Journal:  mBio       Date:  2021-06-22       Impact factor: 7.867

Review 7.  A Systematic Review and Meta-Analysis of the Prevalence and Impact of Pulmonary Bacterial Colonisation in Stable State Chronic Obstructive Pulmonary Disease (COPD).

Authors:  Michael N Armitage; Daniella A Spittle; Alice M Turner
Journal:  Biomedicines       Date:  2021-12-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.